Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
1 other identifier
observational
213
1 country
1
Brief Summary
This proposed study will use previous study results to guide the development and evaluation of interventions to improve CRC screening acceptance. The proposed study will evaluate the impact of three interventions to promote CRC screening among siblings in this increased-risk group, who are not currently compliant with CRC screening guidelines: 1) a generic print intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored telephone counseling intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2003
CompletedFirst Submitted
Initial submission to the registry
December 21, 2007
CompletedFirst Posted
Study publicly available on registry
December 28, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedNovember 7, 2008
November 1, 2008
4.9 years
December 21, 2007
November 6, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phone follow-up interview. Participants will be contacted by study assistant and the survey administered.
6 months after baseling
Study Arms (3)
1
Generic Print Intervention: The generic print intervention will consist of the pamphlet, "Colorectal Cancer Screening Saves Lives" published by the Center for Disease Control that will be mailed to the participant.
2
Tailored Print Intervention: The tailored print intervention will consist of a cover letter detailing the participant's stage of readiness along with a color pamphlet with information personally tailored for the individual participant.
3
Tailored print plus tailored phone intervention: The tailored print plus tailored telephone intervention will consist of a phone counseling session and the tailored print information described above. The tailored print material will serve as a guide during the telephone counseling contact and a reinforcement of the information.
Interventions
Generic Print Intervention: The generic print intervention will consist of the pamphlet, "Colorectal Cancer Screening Saves Lives" published by the Center for Disease Control that will be mailed to the participant.
Tailored Print Intervention: The tailored print intervention will consist of a cover letter detailing the participant's stage of readiness along with a color pamphlet with information personally tailored for the individual participant.
Tailored print plus tailored phone intervention: The tailored print plus tailored telephone intervention will consist of a phone counseling session and the tailored print information described above. The tailored print material will serve as a guide during the telephone counseling contact and a reinforcement of the information.
Eligibility Criteria
You may qualify if:
- How old is the participant? (≥ 18 years)
- Is the participant either:
- currently age 40 or above (YES) OR
- within 10 years of the age at which the patient/proband was initially diagnosed with CRC (whichever is the younger age) (YES)
- Is the participant a full or half biological sibling of the patient/proband? (YES)
You may not qualify if:
- Is the participant currently not compliant with standard CRC screening guidelines? (NO)
- Is the participant English speaking? (YES)
- Does the participant have a primary language other than English? (NO)
- Does the participant have a history of Inflammatory Bowel Disease? (NO)
- Does the participant have a history of colorectal cancer of colorectal polyp? (NO)
- Does the participant have a history of hereditary colorectal cancer syndrome? (Familial Adenomatous Polyposis or Hereditary Nonpolyposis Colorectal Cancer) (NO)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- National Cancer Institute (NCI)collaborator
- Fox Chase Cancer Centercollaborator
- Icahn School of Medicine at Mount Sinaicollaborator
- Lombardi Comprehensive Cancer Centercollaborator
- Micromass Communications, Cary, NCcollaborator
- University of Pennsylvaniacollaborator
- Christiana Care Health Servicescollaborator
- Pinnacle Health Regional Cancer Center, Harrisburg, PAcollaborator
- Temple Universitycollaborator
- St. Mary Regional Cancer Center, Langhorne, PAcollaborator
- South Jersey Regional Cancer Center, Bridgton, New Jerseycollaborator
- Hunterdon Cancer Centercollaborator
- Northeast Regional Cancer Institutecollaborator
- Virtua Memorial Hospital and Virtua Westcollaborator
- Jersey Hospitalcollaborator
- Rutgers Cancer Institute of New Jerseycollaborator
- Massachusetts General Hospitalcollaborator
- Main Line Healthcollaborator
- Roswell Park Cancer Institutecollaborator
- HematologyOncologycollaborator
- Associates of Central New Yorkcollaborator
- Augusta Universitycollaborator
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Arnold Markowitz, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 21, 2007
First Posted
December 28, 2007
Study Start
June 1, 2003
Primary Completion
May 1, 2008
Study Completion
May 1, 2008
Last Updated
November 7, 2008
Record last verified: 2008-11